All other professional, scientific and technical activities n.e.c.
FLEXIPHARMA AS
Revenue 2024
NOK 217,000
Operating profit
NOK 98,000
Equity
NOK 471,000
Incorporated
2013
Share capital
NOK 100,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 217k | |
| Total operating costs | 120k | |
| Operating profit (EBIT) | 98k | |
| Net financial items | −47k | |
| Profit for the year | 30k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 919k | |
| of which current assets | 919k | |
| Equity | 471k | |
| Total liabilities | 448k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.